Mary Ely, NP

NPI: 1639477425
Total Payments
$711.89
2024 Payments
$438.69
Companies
11
Transactions
38
Medicare Patients
327
Medicare Billing
$50,989

Payment Breakdown by Category

Food & Beverage$664.98 (93.4%)
Education$46.91 (6.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $664.98 37 93.4%
Education $46.91 1 6.6%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $161.47 9 $0 (2024)
ITI, Inc. $151.86 6 $0 (2023)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $112.49 5 $0 (2024)
Janssen Pharmaceuticals, Inc $79.65 5 $0 (2024)
Sunovion Pharmaceuticals Inc. $63.11 4 $0 (2022)
Supernus Pharmaceuticals, Inc. $49.68 3 $0 (2024)
Otsuka America Pharmaceutical, Inc. $35.40 2 $0 (2024)
Teva Pharmaceuticals USA, Inc. $16.48 1 $0 (2023)
Neurocrine Biosciences, Inc. $15.76 1 $0 (2024)
IDORSIA PHARMACEUTICALS US INC $13.83 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $438.69 24 ABBVIE INC. ($161.47)
2023 $90.87 5 ITI, Inc. ($60.56)
2022 $170.17 8 ITI, Inc. ($91.30)
2021 $12.16 1 Eisai Inc. ($12.16)

All Payment Transactions

38 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/03/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $17.52 General
Category: VILOXAZINE HYDROCHLORIDE
11/07/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $19.35 General
Category: PSYCHIATRY
11/06/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $15.76 General
Category: Neuropsychiatry
11/01/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $16.26 General
Category: VILOXAZINE HYDROCHLORIDE
10/29/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $16.57 General
Category: Neuroscience
10/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.96 General
Category: NEUROSCIENCE
09/26/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.41 General
Category: NEUROSCIENCE
08/07/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $19.72 General
Category: NEUROSCIENCE
08/06/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $17.96 General
Category: Neuroscience
07/30/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $23.00 General
Category: PSYCHIATRY
07/11/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.22 General
Category: NEUROSCIENCE
07/03/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $15.90 General
Category: VILOXAZINE HYDROCHLORIDE
05/30/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.92 General
Category: NEUROSCIENCE
05/15/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $26.93 General
Category: PSYCHIATRY
05/02/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $8.76 General
Category: NEUROSCIENCE
04/09/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $14.32 General
Category: Neuroscience
03/28/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $16.30 General
Category: Neuroscience
03/22/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $22.45 General
Category: PSYCHIATRY
03/21/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.93 General
Category: NEUROSCIENCE
03/20/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $19.64 General
Category: PSYCHIATRY
03/05/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.35 General
Category: NEUROSCIENCE
01/30/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $20.76 General
Category: PSYCHIATRY
01/30/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $14.50 General
Category: Neuroscience
01/25/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.20 General
Category: NEUROSCIENCE
12/09/2023 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $26.06 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 104 223 $50,245 $12,979
2022 2 53 196 $45,975 $11,479
2021 2 59 220 $52,000 $13,305
2020 4 111 266 $63,245 $13,226
Total Patients
327
Total Services
905
Medicare Billing
$50,989
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 56 160 $34,020 $8,135 23.9%
90792 Psychiatric diagnostic evaluation with medical services Office 2023 31 33 $11,725 $3,974 33.9%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 17 30 $4,500 $869.76 19.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 39 181 $40,725 $9,754 23.9%
90792 Psychiatric diagnostic evaluation with medical services Office 2022 14 15 $5,250 $1,725 32.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 41 200 $45,000 $10,696 23.8%
90792 Psychiatric diagnostic evaluation with medical services Office 2021 18 20 $7,000 $2,609 37.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 57 181 $40,545 $7,933 19.6%
90792 Psychiatric diagnostic evaluation with medical services Office 2020 32 34 $11,900 $3,405 28.6%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 11 39 $7,800 $1,063 13.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 11 12 $3,000 $824.16 27.5%

About Mary Ely, NP

Mary Ely, NP is a Nurse Practitioner healthcare provider based in Cleveland, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2011. The National Provider Identifier (NPI) number assigned to this provider is 1639477425.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Ely, NP has received a total of $711.89 in payments from pharmaceutical and medical device companies, with $438.69 received in 2024. These payments were reported across 38 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($664.98).

As a Medicare-enrolled provider, Ely has provided services to 327 Medicare beneficiaries, totaling 905 services with total Medicare billing of $50,989. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Cleveland, MS
  • Active Since 03/03/2011
  • Last Updated 10/25/2023
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1639477425

Products in Payments

  • CAPLYTA (Drug) $264.35
  • VRAYLAR (Drug) $161.47
  • INVEGA SUSTENNA (Drug) $79.65
  • LATUDA (Drug) $63.11
  • Qelbree (Drug) $49.68
  • REXULTI (Drug) $35.40
  • Austedo XR (Drug) $16.48
  • INGREZZA (Drug) $15.76
  • QUVIVIQ (Drug) $13.83
  • Dayvigo (Drug) $12.16

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Cleveland